Traditional Chinese Medicine Integrated Multifunctional Responsive Core–Shell Microneedles for Dermatosis Treatment
Research · 2024-01 · 7
DOI: 10.34133/research.0420 ↗Kurz gefasst
Fachartikel in der Zeitschrift Research, online erschienen am 04.07.2024. Verfasst von Xi Luan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, School of Pharmacy, Clinical College of Traditional Chinese and Western Medic…. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Natural Science Foundation of Jiangsu Province, Guangdong Basic and Applied Basic Research Foundation, Shenzhen Fundamental Research Program.
Abstract (Originalsprache)
Microneedles have demonstrated value in targeted treatment of dermatosis. Current investigation aims to enhance the functions and optimize substance delivery to improve therapeutic effects. Here, we present innovative shell–core microneedles with light-pH dual responsiveness for spatiotemporal sequential release of multiple Chinese herb drugs to treat scleroderma. By using a stepwise template-assisted method, we effectively prepare a hydrogel-based core layer containing polydopamine-MXene (P-MXene) loaded with triptolide (TP), and a shell layer composed of polyvinyl alcohol (PVA) encapsulating paeoniflorin (Pae). P-MXene can adsorb the sparingly soluble TP to ensure its encapsulation efficiency and contribute to the synergistic photothermal effect benefitting from its excellent photothermal conversion ability. Besides, PVA can rapidly dissolve upon microneedle piercing into the skin and quickly release the anti-inflammatory and detoxifying Pae, establishing a favorable low-acid subcutaneous environment. In response to pH changes and near-infrared effects, TP is sustainably released from P-MXene and delivered through the swollen pores of the hydrogel. On the basis of these characteristics, we demonstrate that these microneedles could effectively reduce profibrotic key cytokines interleukin-1β and transforming growth factor-β, thereby reducing collagen deposition and decreasing epidermal thickness, ameliorating skin fibrosis and capillary lesion in scleroderma mouse models. These findings highlight the important clinical potential of these microneedles in the treatment of skin diseases.
Autor:innen und Institutionen
- Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, School of Pharmacy, Clinical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China.
- State Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, China.
- Shenzhen Research Institute, Southeast University, Shenzhen 518071, China.
ORCID-Profile: Xi Luan, Yuanjin Zhao
Förderung
- Natural Science Foundation of Jiangsu Province
- Guangdong Basic and Applied Basic Research Foundation
- Shenzhen Fundamental Research Program
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Nanjing Medical Science and Technique Development Foundation
- Clinical Trials from Nanjing Drum Tower Hospital
Zitieren
APA
Luan, X., Zhang, X., Luan, Q., Gan, J., Wang, Y., & Zhao, Y. (2024). Traditional Chinese Medicine Integrated Multifunctional Responsive Core–Shell Microneedles for Dermatosis Treatment. Research, 7. https://doi.org/10.34133/research.0420
Vancouver
Luan X, Zhang X, Luan Q, Gan J, Wang Y, Zhao Y. Traditional Chinese Medicine Integrated Multifunctional Responsive Core–Shell Microneedles for Dermatosis Treatment. Research. 2024;7. doi:10.34133/research.0420
BibTeX
@article{Luan2024,
author = {Luan, Xi and Zhang, Xiaoxuan and Luan, Qichen and Gan, Jingjing and Wang, Yu and Zhao, Yuanjin},
title = {Traditional Chinese Medicine Integrated Multifunctional Responsive Core–Shell Microneedles for Dermatosis Treatment},
journal = {Research},
year = {2024},
volume = {7},
doi = {10.34133/research.0420}
}
EUVIMED